Summit Creek Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-310,976
| Closed | -$22.4M | – | 72 |
|
|
2020
Q4 | $22.4M | Sell |
310,976
-122,270
| -28% | -$6.4M | 2.88% | 2 |
|
|
2020
Q3 | $19.7M | Buy |
433,246
+68,300
| +19% | +$2.86M | 2.93% | 3 |
|
|
2020
Q2 | $16.5M | Buy |
364,946
+70,659
| +24% | +$3.17M | 2.43% | 16 |
|
|
2020
Q1 | $11.3M | Sell |
294,287
-36,410
| -11% | -$1.68M | 2.26% | 21 |
|
|
2019
Q4 | $15.3M | Buy |
330,697
+13,877
| +4% | +$601K | 2.39% | 14 |
|
|
2019
Q3 | $12.9M | Buy |
316,820
+13,880
| +5% | +$599K | 2.16% | 20 |
|
|
2019
Q2 | $14.6M | Buy |
302,940
+114,360
| +61% | +$6.01M | 2.45% | 18 |
|
|
2019
Q1 | $11.8M | Sell |
188,580
-10,382
| -5% | -$713K | 2.1% | 21 |
|
|
2018
Q4 | $11.9M | Sell |
198,962
-66,630
| -25% | -$4M | 2.4% | 14 |
|
|
2018
Q3 | $17.1M | Sell |
265,592
-610
| -0.2% | -$34K | 2.74% | 9 |
|
|
2018
Q2 | $12M | Sell |
266,202
-113,880
| -30% | -$4.54M | 2.15% | 19 |
|
|
2018
Q1 | $11.8M | Buy |
380,082
+20
| +0% | +$658 | 2.15% | 23 |
|
|
2017
Q4 | $11.4M | Buy |
380,062
+40,366
| +12% | +$1.17M | 2.13% | 20 |
|
|
2017
Q3 | $11.2M | Sell |
339,696
-2,525
| -0.7% | -$87.5K | 2.21% | 20 |
|
|
2017
Q2 | $11.4M | Buy |
342,221
+69,655
| +26% | +$2.08M | 2.36% | 14 |
|
|
2017
Q1 | $7.89M | Buy |
272,566
+41,184
| +18% | +$1.02M | 1.66% | 31 |
|
|
2016
Q4 | $5.17M | Buy |
+231,382
| New | +$4.52M | 0.88% | 45 |
|
Other funds holding BEAT
Summit Creek Advisors's BEAT Position: Q1 2021 in Review
Summit Creek Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 310,976 shares — an estimated $22.4M sold.
Summit Creek Advisors first reported a position in BEAT in Q4 2016 and held it in 17 quarters. The position peaked at $22.4M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Summit Creek Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Summit Creek Advisors sold 310,976 BioTelemetry, Inc. shares in Q1 2021, an estimated $22.4M.
- Summit Creek Advisors first reported a position in BioTelemetry, Inc. in Q4 2016 and held it in 17 quarters.
- Summit Creek Advisors's BioTelemetry, Inc. position peaked at $22.4M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Summit Creek Advisors's 13F filing for Q1 2021, filed 20 Apr 2021.